Deciphera Receives European Commission Approval of ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
-
17/07/2025, 21:49
-
ansa.it
0
Scopri altro
- 17/09/2025, 21:49
-
ansa.it
-
0
- 17/09/2025, 21:37
-
ansa.it
-
0
- 17/09/2025, 21:31
-
ansa.it
-
0
- 17/09/2025, 21:31
-
ansa.it
-
0
- 17/09/2025, 20:22
-
ansa.it
-
0
- 17/09/2025, 20:13
-
ansa.it
-
0
- 17/09/2025, 20:09
-
ansa.it
-
0
Nessun commento